GH in the dwarf dopaminergic D2 receptor knockout mouse: Somatotrope population, GH release, and responsiveness to GH-releasing factors and somatostatin

Recently, the importance of the dopaminergic D2 receptor (D2R) subtype in normal body growth and neonatal GH secretion has been highlighted. Disruption of D2R alters the GHRH-GH-IGF-I axis and impairs body growth in adult male mice. The D2R knockout (KO) dwarf mouse has not been well characterized;...

Descripción completa

Detalles Bibliográficos
Publicado: 2006
Materias:
Acceso en línea:https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_00220795_v190_n3_p611_GarciaTornadu
http://hdl.handle.net/20.500.12110/paper_00220795_v190_n3_p611_GarciaTornadu
Aporte de:
id paper:paper_00220795_v190_n3_p611_GarciaTornadu
record_format dspace
spelling paper:paper_00220795_v190_n3_p611_GarciaTornadu2023-06-08T14:45:26Z GH in the dwarf dopaminergic D2 receptor knockout mouse: Somatotrope population, GH release, and responsiveness to GH-releasing factors and somatostatin cyclic AMP dopamine dopamine 2 receptor ghrelin growth hormone growth hormone releasing factor growth hormone releasing factor receptor neurotransmitter prolactin somatostatin animal cell animal experiment animal model animal tissue article cell count cell culture concentration (parameters) confocal microscopy controlled study genotype growth hormone release hormonal regulation hormone action hypophysis cell hypothalamus immunohistochemistry in vivo study knockout mouse male molecular mechanics mouse nonhuman pituitary dwarfism priority journal prolactin release sensitivity analysis signal transduction Western blotting wild type Animals Blotting, Western Cells, Cultured Cyclic AMP Dopamine Dose-Response Relationship, Drug Dwarfism Ghrelin Growth Hormone Growth Hormone-Releasing Hormone Immunohistochemistry Male Mice Mice, Knockout Microscopy, Confocal Peptide Hormones Pituitary Gland Prolactin Receptors, Dopamine D2 Receptors, Neuropeptide Receptors, Pituitary Hormone-Regulating Hormone Somatostatin Recently, the importance of the dopaminergic D2 receptor (D2R) subtype in normal body growth and neonatal GH secretion has been highlighted. Disruption of D2R alters the GHRH-GH-IGF-I axis and impairs body growth in adult male mice. The D2R knockout (KO) dwarf mouse has not been well characterized; we therefore sought to determine somatotrope function in the adult pituitary. Using immunohistochemistry and confocal microscopy, we found a significant decrease in the somatotrope population in pituitaries from KO mice (P=0.043), which was paralleled by a decreased GH output from pituitary cells cultured in vitro. In cells from adult mice the response amplitude to GHRH differed between genotypes (lower in KO), but this difference was less dramatic after taking into account the lower basal release and hormone content in the KO cells. Furthermore, there were no significant differences in cAMP generation in response to GHRH between genotypes. By Western blot, GHRH-receptor in pituitary membranes from KO mice was reduced to 46% of the level found in wildtype (WT) mice (P=0.016). Somatostatin induced a concentration-dependent decrease in GH and prolactin (PRL) secretion in both genotypes, and 1 × 10-7 M ghrelin released GH in cells from both genotypes (P=0.017) in a proportionate manner to basal levels. These results suggest that KO somatotropes maintain a regulated secretory function. Finally, we tested the direct effect of dopamine on GH and PRL secretion in cells from both genotypes at 20 days and 6 months of life. As expected, we found that dopamine could reduce PRL levels at both ages in WT mice but not in KO mice, but there was no consistent effect of the neurotransmitter on GH release in either genotype at the ages studied. The present study demonstrates that in the adult male D2R KO mouse, there is a reduction in pituitary GH content and secretory activity. Our results point to an involvement of D2R signaling at the hypothalamic level as dopamine did not release GH acting at the pituitary level either in 1-month-old or adult mice. The similarity of the pituitary defect in the D2R KO mouse to that of GHRH-deficient models suggests a probable mechanism. A loss of dopamine signaling via hypothalamic D2Rs at a critical age causes the reduced release of GHRH from hypophyseotropic neurons leading to inadequate clonal expansion of the somatotrope population. Our data also reveal that somatotrope cell number is much more sensitive to changes in neonatal GHRH input than their capacity to develop properly regulated GH-secretory function. © 2006 Society for Endocrinology. 2006 https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_00220795_v190_n3_p611_GarciaTornadu http://hdl.handle.net/20.500.12110/paper_00220795_v190_n3_p611_GarciaTornadu
institution Universidad de Buenos Aires
institution_str I-28
repository_str R-134
collection Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA)
topic cyclic AMP
dopamine
dopamine 2 receptor
ghrelin
growth hormone
growth hormone releasing factor
growth hormone releasing factor receptor
neurotransmitter
prolactin
somatostatin
animal cell
animal experiment
animal model
animal tissue
article
cell count
cell culture
concentration (parameters)
confocal microscopy
controlled study
genotype
growth hormone release
hormonal regulation
hormone action
hypophysis cell
hypothalamus
immunohistochemistry
in vivo study
knockout mouse
male
molecular mechanics
mouse
nonhuman
pituitary dwarfism
priority journal
prolactin release
sensitivity analysis
signal transduction
Western blotting
wild type
Animals
Blotting, Western
Cells, Cultured
Cyclic AMP
Dopamine
Dose-Response Relationship, Drug
Dwarfism
Ghrelin
Growth Hormone
Growth Hormone-Releasing Hormone
Immunohistochemistry
Male
Mice
Mice, Knockout
Microscopy, Confocal
Peptide Hormones
Pituitary Gland
Prolactin
Receptors, Dopamine D2
Receptors, Neuropeptide
Receptors, Pituitary Hormone-Regulating Hormone
Somatostatin
spellingShingle cyclic AMP
dopamine
dopamine 2 receptor
ghrelin
growth hormone
growth hormone releasing factor
growth hormone releasing factor receptor
neurotransmitter
prolactin
somatostatin
animal cell
animal experiment
animal model
animal tissue
article
cell count
cell culture
concentration (parameters)
confocal microscopy
controlled study
genotype
growth hormone release
hormonal regulation
hormone action
hypophysis cell
hypothalamus
immunohistochemistry
in vivo study
knockout mouse
male
molecular mechanics
mouse
nonhuman
pituitary dwarfism
priority journal
prolactin release
sensitivity analysis
signal transduction
Western blotting
wild type
Animals
Blotting, Western
Cells, Cultured
Cyclic AMP
Dopamine
Dose-Response Relationship, Drug
Dwarfism
Ghrelin
Growth Hormone
Growth Hormone-Releasing Hormone
Immunohistochemistry
Male
Mice
Mice, Knockout
Microscopy, Confocal
Peptide Hormones
Pituitary Gland
Prolactin
Receptors, Dopamine D2
Receptors, Neuropeptide
Receptors, Pituitary Hormone-Regulating Hormone
Somatostatin
GH in the dwarf dopaminergic D2 receptor knockout mouse: Somatotrope population, GH release, and responsiveness to GH-releasing factors and somatostatin
topic_facet cyclic AMP
dopamine
dopamine 2 receptor
ghrelin
growth hormone
growth hormone releasing factor
growth hormone releasing factor receptor
neurotransmitter
prolactin
somatostatin
animal cell
animal experiment
animal model
animal tissue
article
cell count
cell culture
concentration (parameters)
confocal microscopy
controlled study
genotype
growth hormone release
hormonal regulation
hormone action
hypophysis cell
hypothalamus
immunohistochemistry
in vivo study
knockout mouse
male
molecular mechanics
mouse
nonhuman
pituitary dwarfism
priority journal
prolactin release
sensitivity analysis
signal transduction
Western blotting
wild type
Animals
Blotting, Western
Cells, Cultured
Cyclic AMP
Dopamine
Dose-Response Relationship, Drug
Dwarfism
Ghrelin
Growth Hormone
Growth Hormone-Releasing Hormone
Immunohistochemistry
Male
Mice
Mice, Knockout
Microscopy, Confocal
Peptide Hormones
Pituitary Gland
Prolactin
Receptors, Dopamine D2
Receptors, Neuropeptide
Receptors, Pituitary Hormone-Regulating Hormone
Somatostatin
description Recently, the importance of the dopaminergic D2 receptor (D2R) subtype in normal body growth and neonatal GH secretion has been highlighted. Disruption of D2R alters the GHRH-GH-IGF-I axis and impairs body growth in adult male mice. The D2R knockout (KO) dwarf mouse has not been well characterized; we therefore sought to determine somatotrope function in the adult pituitary. Using immunohistochemistry and confocal microscopy, we found a significant decrease in the somatotrope population in pituitaries from KO mice (P=0.043), which was paralleled by a decreased GH output from pituitary cells cultured in vitro. In cells from adult mice the response amplitude to GHRH differed between genotypes (lower in KO), but this difference was less dramatic after taking into account the lower basal release and hormone content in the KO cells. Furthermore, there were no significant differences in cAMP generation in response to GHRH between genotypes. By Western blot, GHRH-receptor in pituitary membranes from KO mice was reduced to 46% of the level found in wildtype (WT) mice (P=0.016). Somatostatin induced a concentration-dependent decrease in GH and prolactin (PRL) secretion in both genotypes, and 1 × 10-7 M ghrelin released GH in cells from both genotypes (P=0.017) in a proportionate manner to basal levels. These results suggest that KO somatotropes maintain a regulated secretory function. Finally, we tested the direct effect of dopamine on GH and PRL secretion in cells from both genotypes at 20 days and 6 months of life. As expected, we found that dopamine could reduce PRL levels at both ages in WT mice but not in KO mice, but there was no consistent effect of the neurotransmitter on GH release in either genotype at the ages studied. The present study demonstrates that in the adult male D2R KO mouse, there is a reduction in pituitary GH content and secretory activity. Our results point to an involvement of D2R signaling at the hypothalamic level as dopamine did not release GH acting at the pituitary level either in 1-month-old or adult mice. The similarity of the pituitary defect in the D2R KO mouse to that of GHRH-deficient models suggests a probable mechanism. A loss of dopamine signaling via hypothalamic D2Rs at a critical age causes the reduced release of GHRH from hypophyseotropic neurons leading to inadequate clonal expansion of the somatotrope population. Our data also reveal that somatotrope cell number is much more sensitive to changes in neonatal GHRH input than their capacity to develop properly regulated GH-secretory function. © 2006 Society for Endocrinology.
title GH in the dwarf dopaminergic D2 receptor knockout mouse: Somatotrope population, GH release, and responsiveness to GH-releasing factors and somatostatin
title_short GH in the dwarf dopaminergic D2 receptor knockout mouse: Somatotrope population, GH release, and responsiveness to GH-releasing factors and somatostatin
title_full GH in the dwarf dopaminergic D2 receptor knockout mouse: Somatotrope population, GH release, and responsiveness to GH-releasing factors and somatostatin
title_fullStr GH in the dwarf dopaminergic D2 receptor knockout mouse: Somatotrope population, GH release, and responsiveness to GH-releasing factors and somatostatin
title_full_unstemmed GH in the dwarf dopaminergic D2 receptor knockout mouse: Somatotrope population, GH release, and responsiveness to GH-releasing factors and somatostatin
title_sort gh in the dwarf dopaminergic d2 receptor knockout mouse: somatotrope population, gh release, and responsiveness to gh-releasing factors and somatostatin
publishDate 2006
url https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_00220795_v190_n3_p611_GarciaTornadu
http://hdl.handle.net/20.500.12110/paper_00220795_v190_n3_p611_GarciaTornadu
_version_ 1768545912298143744